JMP Securities Upgrades Myriad Genetics (MYGN) to Market Outperform
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $3.18 -0.31%
Rating Summary:
6 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Rating Summary:
6 Buy, 19 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 26 | Down: 25 | New: 65
Join SI Premium – FREE
JMP Securities upgraded Myriad Genetics (NASDAQ: MYGN) from Market Perform to Market Outperform with a price target of $48.00.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $32.01 yesterday.
For an analyst ratings summary and ratings history on Myriad Genetics click here. For more ratings news on Myriad Genetics click here.
Shares of Myriad Genetics closed at $32.01 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Upgrades Airbnb Inc. (ABNB) to Outperform
- Mizuho Upgrades Vivmark Residential (VMRK) to Outperform, 'relatively favorable GARP profile'
- Citi upgrades C.H. Robinson to Buy with $185 target, Opens 90-Day upside catalyst watch
Create E-mail Alert Related Categories
UpgradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
